Cover Image
Market Research Report

Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volume & Price. Forecasts by Chemistry, Hematology, Microbiology, Pathology, Molecular Diagnostic and Esoteric by Country.

Published by Howe Sound Research Product code 933293
Published Content info 340 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volume & Price. Forecasts by Chemistry, Hematology, Microbiology, Pathology, Molecular Diagnostic and Esoteric by Country.
Published: May 1, 2020 Content info: 340 Pages
Description

Title:
Global Clinical In Vitro Diagnostic Medical Laboratory Services Market.
Strategies & Trends. Volume & Price. Forecasts by Chemistry, Hematology, Microbiology, Pathology, Molecular Diagnostic and Esoteric by Country. Updated with Impact of COVID-19 Pandemic. Situation Analysis and Executive & Consultant Guides. 2020 to 2024.

OVERVIEW:

The Clinical Laboratory has seen steady growth for the last 20 years, but this is changing with the effect of the COVID pandemic on healthcare and economic activity. Worse still, Point of Care and Self Testing are threatening long term demand. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations.

Trends like ......

  • the genetic blizzard
  • emerging economies and global prosperity
  • pharmacogenomics
  • healthcare expansion in China
  • climate change
  • globalization
  • automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School
Table of Contents

Table of Contents

i. Clinical Laboratory Services - Strategic Situation Analysis and Impact Analysis of COVID Recession

ii. Guide for Executives, Marketing, Sales and Business Development Staff

iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition

  • 1.1. The Growing Demand for Clinical Testing
  • 1.2. Defining the Opportunity
    • 1.2.1. Volumes
    • 1.2.2. Prices
    • 1.2.3. Revenue Market Size
  • 1.3. Methods and Sources
    • 1.3.1. Authors
    • 1.3.2. Sources
  • 1.4. U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1. U.S. Medicare Expenditures for Laboratory Testing

2. Overview of a Dynamic Market

  • 2.1. Market Players - Roles & Impacts
    • 2.1.1. Supplier/pharmaceutical
    • 2.1.2. Independent lab specialized/esoteric
    • 2.1.3. Independent lab national/regional
    • 2.1.4. Independent lab analytical
    • 2.1.5. Public National/regional lab
    • 2.1.6. Hospital lab
    • 2.1.7. Physician lab
    • 2.1.8. Audit body
  • 2.2. Segmentation - Different Approaches
    • 2.2.1. Traditional Market Segmentation
    • 2.2.2. Laboratory Focus and Segmentation
  • 2.3. Structure of Clinical Testing Industry
    • 2.3.1. The Hospital Lab - Share of the Pie
    • 2.3.2. Key Role for Economies of Scale
    • 2.3.3. Physician Office Lab's are Still Here
    • 2.3.4. Physician's and POCT - Reviving Patient Service in China
  • 2.4. Profiles of Key Companies
    • Acibadem Labmed Laboratory
    • ACM Medical Laboratory
    • Adicon Clinical Laboratories
    • American Bio-Clinical Laboratories, Int'l
    • American Pathology Partners
    • ARUP Laboratories
    • Ascend Clinical
    • Aurora Diagnostics
    • Bio-Reference Laboratories
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • BP Healthcare Group
    • Clinical Reference Laboratory
    • Clongen Laboratories
    • CompuNet Clinical Laboratories
    • Diagnósticos da América
    • DIAN Diagnostics Co., Ltd
    • Enzo Life Sciences, Inc
    • Eurofins Scientific
    • Exagen Diagnostics
    • Genomic Health
    • Genzyme Corporation
    • Gribbles Pathology
    • Guangzhou Kingmed Diagnostics Group Co., Ltd
    • Integrated Regional Laboratories
    • KDL Group
    • Laboratory Corporation of America
    • Lifelabs
    • Mayo Clinic Laboratories
    • Mid America Clinical Laboratories
    • Myriad Genetics/Myriad RBM
    • NeoGenomics
    • Pathology, Inc
    • Psychemedics Corporation
    • Quest Diagnostics
    • RDL Reference Laboratory
    • Sonic Healthcare
    • Spectra Laboratories
    • Synlab Group
    • Unilabs
  • 2.5. National and Regional Diversity

3. Trends Driving a Changing Market

  • 3.1. Growth Is Pushed from Many Sides
    • 3.1.1. Understanding the Impact of Aging Population
    • 3.1.2. COVID Related Testing Growth
    • 3.1.3. Point of Care Testing can increase demand
    • 3.1.4. Alternative Medicine Creates Testing Opportunity
    • 3.1.5. Esoteric Testing Moving Mainstream
    • 3.1.6. Genetic Based Testing Creates New Department and New Discipline
  • 3.2. Factors at Work To Shrink The Market
    • 3.2.1. COVID 19 Recession
    • 3.2.2. Economic or population contraction
    • 3.2.3. Testing usage analysis curtailing growth
    • 3.2.4. Wellness has a downside
    • 3.2.5. Test Displacement Impacts Important
    • 3.2.6. Point of Care Testing
  • 3.3. Automation
    • 3.3.1. Stranded LIMS Investment
    • 3.3.2. Software as a Service
    • 3.3.3. Physician Office and Access Systems
  • 3.4. Environment and Evolution
  • 3.5. Diagnostic Technology Development
    • 3.5.1. Next Generation Sequencing Fuels a Revolution
    • 3.5.2. Impact of NGS on pricing
    • 3.5.3. POCT/Self Testing Disruptive Force
    • 3.5.4. Pharmacogenomics Blurs Diagnosis and Treatment
    • 3.5.5. CGES Testing, A Brave New World
    • 3.5.6. Molecular Diagnostics Technologies at The Forefront of Growth
    • 3.5.7. Biochips/Giant magneto resistance based assay

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments

  • 4.1. Recent Developments - Importance and How to Use This Section
    • 4.1.1. Importance of These Developments
    • 4.1.2. How to Use This Section
      • Private labs say demand for coronavirus tests is down
      • CDC Ranks Two More Microbes as ‘Urgent Threat'
      • Applied Biology to Launch New Laboratory for Hair and Skin Disorders
      • Quest Diagnostics Acquires Outreach Operations
      • Quest Diagnostics Buys Assets of Boston Clinical Laboratory Services
      • CLA Urges FDA to Halt Crackdown on PGx Testing
      • ACLA Requests $5 billion to keep private labs going
      • Quest Diagnostics Subsidiary Buys True Health Dx Assets
      • BioReference Laboratories selected by IPA Association
      • Predictive Laboratories Announces Research Collaboration
      • NEOMED-LABS / Pacific Biomarkers Acquires PAIRimmune Français
      • LabCorp and Envigo Complete Transactions
      • PathGroup Acquires Pathologists Bio-Medical Laboratories
      • Predictive Technology Acquires Taueret Laboratories
      • Quest Diagnostics Acquires Laboratory Services Business of Boyce & Bynum Pathology Laboratories
      • Gestalt Diagnostics Expands Market Reach with Peak Medical Acquisition
      • Amazon exploring consumer health diagnostics
      • Quest Diagnostics Acquires Laboratory Services Operation in Central Michigan
      • NeoGenomics to acquire Genoptix, Inc
      • Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
      • Charles River Labs to acquire contract research firm for $800M
      • GROUPE BIO7 to be Sold to CERBA HEALTHCARE
      • GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
      • Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies
      • PSP to acquire European medical lab services company
      • Mars, Incorporated to Acquire VCA Inc
      • Grifols acquires Hologic's blood screening unit for $1.85bn
      • LabCorp to acquire clinical laboratories from Mount Sinai
      • PerkinElmer to buy Germany's Euroimmun for about $1.3 billion
      • LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash
      • Precipio Diagnostics and Transgenomic Complete Merger
      • $550 Dock Turns a Smartphone into a Medical Lab
      • LabCorp & Interpace Extend Deal, Boost Cancer Portfolio
      • Quest Diagnostics to Acquire Shiel Medical Laboratory from Fresenius Medical Care
      • Quest Diagnostics to Acquire MedXM
      • Overview of Clinical Diagnostic Acquisition Activity
      • New Sysmex Device Provides Blood Test Results at Point of Care in Minutes
      • FDA, Congress Return Attention to Direct-to-Consumer Genetic Testing
      • QIAGEN Enters into Agreement to Acquire STAT-Dx

5. Country Market Sizes - North America 2016 to 2024

  • 5.1. United States of America 2016 to 2024
    • 5.1.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 5.1.2. Microbiology - Volumes, Prices, Revenues
    • 5.1.3. Hematology - Volumes, Prices, Revenues
    • 5.1.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 5.1.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 5.1.6. All Clinical Testing - Volumes, Prices, Revenues
    • 5.1.7. Esoteric - Volumes, Prices, Revenues
  • 5.2. Canada 2016 to 2024
    • 5.2.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 5.2.2. Microbiology - Volumes, Prices, Revenues
    • 5.2.3. Hematology - Volumes, Prices, Revenues
    • 5.2.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 5.2.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 5.2.6. All Clinical Testing - Volumes, Prices, Revenues
    • 5.2.7. Esoteric - Volumes, Prices, Revenues

6. Country Markets - Europe 2016 to 2024

  • 6.1. France 2016 to 2024
    • 6.1.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 6.1.2. Microbiology - Volumes, Prices, Revenues
    • 6.1.3. Hematology - Volumes, Prices, Revenues
    • 6.1.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 6.1.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.1.6. All Clinical Testing - Volumes, Prices, Revenues
    • 6.1.7. Esoteric - Volumes, Prices, Revenues
  • 6.2. Germany 2016 to 2024
    • 6.2.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 6.2.2. Microbiology - Volumes, Prices, Revenues
    • 6.2.3. Hematology - Volumes, Prices, Revenues
    • 6.2.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 6.2.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.2.6. All Clinical Testing - Volumes, Prices, Revenues
    • 6.2.7. Esoteric - Volumes, Prices, Revenues
  • 6.3. United Kingdom 2016 to 2024
    • 6.3.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 6.3.2. Microbiology - Volumes, Prices, Revenues
    • 6.3.3. Hematology - Volumes, Prices, Revenues
    • 6.3.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 6.3.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.3.6. All Clinical Testing - Volumes, Prices, Revenues
    • 6.3.7. Esoteric - Volumes, Prices, Revenues
  • 6.4. Spain 2016 to 2024
    • 6.4.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 6.4.2. Microbiology - Volumes, Prices, Revenues
    • 6.4.3. Hematology - Volumes, Prices, Revenues
    • 6.4.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 6.4.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.4.6. All Clinical Testing - Volumes, Prices, Revenues
    • 6.4.7. Esoteric - Volumes, Prices, Revenues
  • 6.5. Italy 2016 to 2024
    • 6.5.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 6.5.2. Microbiology - Volumes, Prices, Revenues
    • 6.5.3. Hematology - Volumes, Prices, Revenues
    • 6.5.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 6.5.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.5.6. All Clinical Testing - Volumes, Prices, Revenues
    • 6.5.7. Esoteric - Volumes, Prices, Revenues
  • 6.6. Russia 2016 to 2024
    • 6.6.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 6.6.2. Microbiology - Volumes, Prices, Revenues
    • 6.6.3. Hematology - Volumes, Prices, Revenues
    • 6.6.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 6.6.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.6.6. All Clinical Testing - Volumes, Prices, Revenues
    • 6.6.7. Esoteric - Volumes, Prices, Revenues
  • 6.7. Remainder of Europe and Former Soviet Union 2016 to 2024
    • 6.7.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 6.7.2. Microbiology - Volumes, Prices, Revenues
    • 6.7.3. Hematology - Volumes, Prices, Revenues
    • 6.7.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 6.7.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 6.7.6. All Clinical Testing - Volumes, Prices, Revenues
    • 6.7.7. Esoteric - Volumes, Prices, Revenues

7. Country Markets - Asia Pacific 2016 to 2024

  • 7.1. China 2016 to 2024
    • 7.1.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 7.1.2. Microbiology - Volumes, Prices, Revenues
    • 7.1.3. Hematology - Volumes, Prices, Revenues
    • 7.1.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 7.1.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.1.6. All Clinical Testing - Volumes, Prices, Revenues
    • 7.1.7. Esoteric - Volumes, Prices, Revenues
  • 7.2. Japan 2016 to 2024
    • 7.2.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 7.2.2. Microbiology - Volumes, Prices, Revenues
    • 7.2.3. Hematology - Volumes, Prices, Revenues
    • 7.2.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 7.2.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.2.6. All Clinical Testing - Volumes, Prices, Revenues
    • 7.2.7. Esoteric - Volumes, Prices, Revenues
  • 7.3. South Korea 2016 to 2024
    • 7.3.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 7.3.2. Microbiology - Volumes, Prices, Revenues
    • 7.3.3. Hematology - Volumes, Prices, Revenues
    • 7.3.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 7.3.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.3.6. All Clinical Testing - Volumes, Prices, Revenues
    • 7.3.7. Esoteric - Volumes, Prices, Revenues
  • 7.4. India 2016 to 2024
    • 7.4.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 7.4.2. Microbiology - Volumes, Prices, Revenues
    • 7.4.3. Hematology - Volumes, Prices, Revenues
    • 7.4.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 7.4.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.4.6. All Clinical Testing - Volumes, Prices, Revenues
    • 7.4.7. Esoteric - Volumes, Prices, Revenues
  • 7.5. Australia 2016 to 2024
    • 7.5.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 7.5.2. Microbiology - Volumes, Prices, Revenues
    • 7.5.3. Hematology - Volumes, Prices, Revenues
    • 7.5.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 7.5.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.5.6. All Clinical Testing - Volumes, Prices, Revenues
    • 7.5.7. Esoteric - Volumes, Prices, Revenues
  • 7.6. Rest of Asia Pacific 2016 to 2024
    • 7.6.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 7.6.2. Microbiology - Volumes, Prices, Revenues
    • 7.6.3. Hematology - Volumes, Prices, Revenues
    • 7.6.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 7.6.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 7.6.6. All Clinical Testing - Volumes, Prices, Revenues
    • 7.6.7. Esoteric - Volumes, Prices, Revenues

8. Country Markets - Latin America, Africa & The Middle East 2016 to 2024

  • 8.1. Brazil 2016 to 2024
    • 8.1.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 8.1.2. Microbiology - Volumes, Prices, Revenues
    • 8.1.3. Hematology - Volumes, Prices, Revenues
    • 8.1.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 8.1.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 8.1.6. All Clinical Testing - Volumes, Prices, Revenues
    • 8.1.7. Esoteric - Volumes, Prices, Revenues
  • 8.2. Mexico 2016 to 2024
    • 8.2.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 8.2.2. Microbiology - Volumes, Prices, Revenues
    • 8.2.3. Hematology - Volumes, Prices, Revenues
    • 8.2.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 8.2.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 8.2.6. All Clinical Testing - Volumes, Prices, Revenues
    • 8.2.7. Esoteric - Volumes, Prices, Revenues
  • 8.3. Remainder of Latin America 2016 to 2024
    • 8.3.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 8.3.2. Microbiology - Volumes, Prices, Revenues
    • 8.3.3. Hematology - Volumes, Prices, Revenues
    • 8.3.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 8.3.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 8.3.6. All Clinical Testing - Volumes, Prices, Revenues
    • 8.3.7. Esoteric - Volumes, Prices, Revenues
  • 8.4. Africa & The Middle East 2016 to 2024
    • 8.4.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 8.4.2. Microbiology - Volumes, Prices, Revenues
    • 8.4.3. Hematology - Volumes, Prices, Revenues
    • 8.4.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 8.4.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 8.4.6. All Clinical Testing - Volumes, Prices, Revenues
    • 8.4.7. Esoteric - Volumes, Prices, Revenues

9. Global Market Summary 2016 to 2024

  • 9.1. Global Market 2016 to 2024
    • 9.1.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 9.1.2. Microbiology - Volumes, Prices, Revenues
    • 9.1.3. Hematology - Volumes, Prices, Revenues
    • 9.1.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 9.1.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 9.1.6. All Clinical Testing - Volumes, Prices, Revenues
    • 9.1.7. Esoteric - Volumes, Prices, Revenues

10. The Future of the Clinical Laboratory

11. Additional Country Breakouts McKinsey

  • 11.1. Switzerland 2016 to 2024
    • 11.1.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 11.1.2. Microbiology - Volumes, Prices, Revenues
    • 11.1.3. Hematology - Volumes, Prices, Revenues
    • 11.1.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 11.1.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 11.1.6. All Clinical Testing - Volumes, Prices, Revenues
    • 11.1.7. Esoteric - Volumes, Prices, Revenues
  • 11.2. Portugal 2016 to 2024
    • 11.2.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 11.2.2. Microbiology - Volumes, Prices, Revenues
    • 11.2.3. Hematology - Volumes, Prices, Revenues
    • 11.2.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 11.2.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 11.2.6. All Clinical Testing - Volumes, Prices, Revenues
    • 11.2.7. Esoteric - Volumes, Prices, Revenues
  • 11.3. Norway 2016 to 2024
    • 11.3.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 11.3.2. Microbiology - Volumes, Prices, Revenues
    • 11.3.3. Hematology - Volumes, Prices, Revenues
    • 11.3.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 11.3.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 11.3.6. All Clinical Testing - Volumes, Prices, Revenues
    • 11.3.7. Esoteric - Volumes, Prices, Revenues
  • 11.4. Sweden 2016 to 2024
    • 11.4.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 11.4.2. Microbiology - Volumes, Prices, Revenues
    • 11.4.3. Hematology - Volumes, Prices, Revenues
    • 11.4.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 11.4.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 11.4.6. All Clinical Testing - Volumes, Prices, Revenues
    • 11.4.7. Esoteric - Volumes, Prices, Revenues
  • 11.5. Benelux 2016 to 2024
    • 11.5.1. Clinical Chemistry - Volumes, Prices, Revenues
    • 11.5.2. Microbiology - Volumes, Prices, Revenues
    • 11.5.3. Hematology - Volumes, Prices, Revenues
    • 11.5.4. Anatomic Pathology - Volumes, Prices, Revenues
    • 11.5.5. Molecular Diagnostics - Volumes, Prices, Revenues
    • 11.5.6. All Clinical Testing - Volumes, Prices, Revenues
    • 11.5.7. Esoteric - Volumes, Prices, Revenues

Appendices

  • I. United States Medicare System: January 2019 Clinical Laboratory Fees Schedule

Table of Tables

  • Table 1: Lab Spending 2014 to 2024
  • Table 2: Market Players by Type
  • Table 3: Clinical Laboratory Departments and Segments
  • Table 4: Laboratory Management Focus - Different Approaches
  • Table 5: Key Segmentation Variables Going Forward
  • Table 6: Factors Affecting Local Clinical Testing Demand
  • Table 7: Seven Factors Driving Growth
  • Table 8: Alternative Medicine Creates New Clinical Testing Markets
  • Table 9: Six Factors Limiting Growth
  • Table 10: Key Diagnostic Laboratory Technology Trends
  • Table 11: Next Generation Sequencing Technologies - Speed and Cost
  • Table 12: Key Point of Care Testing Uses
  • Table 13: Clinical Application Areas for Molecular Diagnostics
  • Table 14: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 15: Microbiology - Volume Price and Revenue Forecast
  • Table 16: Hematology - Volume Price and Revenue Forecast
  • Table 17: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 18: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 19: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 20: Esoteric - Volume Price and Revenue Forecast
  • Table 21: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 22: Microbiology - Volume Price and Revenue Forecast
  • Table 23: Hematology - Volume Price and Revenue Forecast
  • Table 24: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 25: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 26: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 27: Esoteric - Volume Price and Revenue Forecast
  • Table 28: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 29: Microbiology - Volume Price and Revenue Forecast
  • Table 30: Hematology - Volume Price and Revenue Forecast
  • Table 31: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 32: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 33: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 34: Esoteric - Volume Price and Revenue Forecast
  • Table 35: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 36: Microbiology - Volume Price and Revenue Forecast
  • Table 37: Hematology - Volume Price and Revenue Forecast
  • Table 38: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 39: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 40: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 41: Esoteric - Volume Price and Revenue Forecast
  • Table 42: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 43: Microbiology - Volume Price and Revenue Forecast
  • Table 44: Hematology - Volume Price and Revenue Forecast
  • Table 45: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 46: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 47: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 48: Esoteric - Volume Price and Revenue Forecast
  • Table 49: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 50: Microbiology - Volume Price and Revenue Forecast
  • Table 51: Hematology - Volume Price and Revenue Forecast
  • Table 52: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 53: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 54: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 55: Esoteric - Volume Price and Revenue Forecast
  • Table 56: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 57: Microbiology - Volume Price and Revenue Forecast
  • Table 58: Hematology - Volume Price and Revenue Forecast
  • Table 59: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 60: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 61: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 62: Esoteric - Volume Price and Revenue Forecast
  • Table 63: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 64: Microbiology - Volume Price and Revenue Forecast
  • Table 65: Hematology - Volume Price and Revenue Forecast
  • Table 66: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 67: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 68: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 69: Esoteric - Volume Price and Revenue Forecast
  • Table 70: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 71: Microbiology - Volume Price and Revenue Forecast
  • Table 72: Hematology - Volume Price and Revenue Forecast
  • Table 73: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 74: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 75: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 76: Esoteric - Volume Price and Revenue Forecast
  • Table 77: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 78: Microbiology - Volume Price and Revenue Forecast
  • Table 79: Hematology - Volume Price and Revenue Forecast
  • Table 80: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 81: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 82: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 83: Esoteric - Volume Price and Revenue Forecast
  • Table 84: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 85: Microbiology - Volume Price and Revenue Forecast
  • Table 86: Hematology - Volume Price and Revenue Forecast
  • Table 87: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 88: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 89: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 90: Esoteric - Volume Price and Revenue Forecast
  • Table 91: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 92: Microbiology - Volume Price and Revenue Forecast
  • Table 93: Hematology - Volume Price and Revenue Forecast
  • Table 94: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 95: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 96: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 97: Esoteric - Volume Price and Revenue Forecast
  • Table 98: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 99: Microbiology - Volume Price and Revenue Forecast
  • Table 100: Hematology - Volume Price and Revenue Forecast
  • Table 101: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 102: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 103: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 104: Esoteric - Volume Price and Revenue Forecast
  • Table 105: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 106: Microbiology - Volume Price and Revenue Forecast
  • Table 107: Hematology - Volume Price and Revenue Forecast
  • Table 108: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 109: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 110: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 111: Esoteric - Volume Price and Revenue Forecast
  • Table 112: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 113: Microbiology - Volume Price and Revenue Forecast
  • Table 114: Hematology - Volume Price and Revenue Forecast
  • Table 115: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 116: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 117: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 118: Esoteric - Volume Price and Revenue Forecast
  • Table 119: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 120: Microbiology - Volume Price and Revenue Forecast
  • Table 121: Hematology - Volume Price and Revenue Forecast
  • Table 122: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 123: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 124: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 125: Esoteric - Volume Price and Revenue Forecast
  • Table 126: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 127: Microbiology - Volume Price and Revenue Forecast
  • Table 128: Hematology - Volume Price and Revenue Forecast
  • Table 129: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 130: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 131: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 132: Esoteric - Volume Price and Revenue Forecast
  • Table 133: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 134: Microbiology - Volume Price and Revenue Forecast
  • Table 135: Hematology - Volume Price and Revenue Forecast
  • Table 136: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 137: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 138: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 139: Esoteric - Volume Price and Revenue Forecast
  • Table 140: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 141: Microbiology - Volume Price and Revenue Forecast
  • Table 142: Hematology - Volume Price and Revenue Forecast
  • Table 143: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 144: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 145: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 146: Esoteric - Volume Price and Revenue Forecast
  • Table 147: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 148: Microbiology - Volume Price and Revenue Forecast
  • Table 149: Hematology - Volume Price and Revenue Forecast
  • Table 150: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 151: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 152: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 153: Esoteric - Volume Price and Revenue Forecast
  • TABLE 154: CLINICAL CHEMISTRY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 155: MICROBIOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 156: HEMATOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 157: ANATOMIC PATHOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 158: MOLECULAR DIAGNOSTICS - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 159: ALL CLINICAL TESTING - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 160: ESOTERIC - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 161: CLINICAL CHEMISTRY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 162: MICROBIOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 163: HEMATOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 164: ANATOMIC PATHOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 165: MOLECULAR DIAGNOSTICS - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 166: ALL CLINICAL TESTING - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 167: ESOTERIC - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 168: CLINICAL CHEMISTRY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 169: MICROBIOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 170: HEMATOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 171: ANATOMIC PATHOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 172: MOLECULAR DIAGNOSTICS - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 173: ALL CLINICAL TESTING - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 174: ESOTERIC - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 175: CLINICAL CHEMISTRY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 176: MICROBIOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 177: HEMATOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 178: ANATOMIC PATHOLOGY - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 179: MOLECULAR DIAGNOSTICS - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 180: ALL CLINICAL TESTING - VOLUME PRICE AND REVENUE FORECAST
  • TABLE 181: ESOTERIC - VOLUME PRICE AND REVENUE FORECAST
  • Table 182: Clinical Chemistry - Volume Price and Revenue Forecast
  • Table 183: Microbiology - Volume Price and Revenue Forecast
  • Table 184: Hematology - Volume Price and Revenue Forecast
  • Table 185: Anatomic Pathology - Volume Price and Revenue Forecast
  • Table 186: Molecular Diagnostics - Volume Price and Revenue Forecast
  • Table 187: All Clinical Testing - Volume Price and Revenue Forecast
  • Table 188: Esoteric - Volume Price and Revenue Forecast
  • Table 189: 2019 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Clinical Lab Spending 2014 to 2024
Back to Top